Florida Pediatric Group Pa

CLIA Laboratory Citation Details

3
Total Citations
9
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 10D1032296
Address 250 S Wickham Rd, West Melbourne, FL, 32904
City West Melbourne
State FL
Zip Code32904
Phone321 752-5210
Lab DirectorMAGED FARID

Citation History (3 surveys)

Survey - December 12, 2023

Survey Type: Standard

Survey Event ID: 0TMK11

Deficiency Tags: D0000 D6045 D5429 D6046

Summary:

Summary Statement of Deficiencies D0000 A recertification survey was conducted from December 8, 2023 to December 12, 2023. Florida Pediatric Group PA clinical laboratory was not in compliance with 42 CFR 493, requirements for clinical laboratories. D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory must perform and document maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: Based on review of the maintenance logs, and interview, the laboratory failed to document the semi annual maintenance on the Cell-DYN Emerald hematology analyzer from 09/01/2023 to 12/08/2023. Findings: Review of the Cell-DYN Emerald maintenance logs noted to lubricate the pistons semi-annually. Review of the Cell- DYN Emerald maintenance logs showed the lubrication of the pistons was not documented. On 12/08/2023 at 12:47 PM, Testing Personnel A stated she did lubricate the pistons, but failed to document it on the maintenance logs. D6045 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(7) (b) The technical consultant is responsible for-- (b)(7) Identifying training needs and assuring that each individual performing tests receives regular in-service training and education appropriate for the type and complexity of the laboratory services performed; This STANDARD is not met as evidenced by: Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Based on review of personnel records, and interview, the laboratory failed to document the initial training of four (D, E, F, G) of seven testing personnel (A to G) hired in 2023. Findings: Review of personnel documents showed there were no records of the training for Testing Personnel D, E, F, or G. On 12/08/2023 at 1:35 PM, Testing Personnel A stated she did not think the Laboratory Director had any documentation of training for the employees hired in 2023. On 12/12/23 in an email correspondence, Testing Personnel A reported Testing Personnel D was hired on 03/31 /2023, Testing Personnel E was hired on 10/16/2023, Testing Personnel F was hired on 04/25/2023, and Testing Personnel G was hired on 10/02/2023 D6046 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(8) (b) The technical consultant is responsible for-- (b)(8) Evaluating the competency of all testing personnel and assuring that the staff maintain their competency to perform test procedures and report test results promptly, accurately and proficiently. This STANDARD is not met as evidenced by: Based on review of competency evaluations, and interview, the Technical Consultant (Laboratory Director) failed to evaluate competency of testing personnel listed on the Laboratory's Personnel Report for seven of seven testing personnel (A, B, C, D, E, F, G) for 2022 and 2023. Findings: Review of the Laboratory Personnel Report signed by the Laboratory Director on 12/06/2023 showed there were eight employees listed on the form, that included the Laboratory Director and seven Testing Personnel. The Laboratory Director was also listed as the Clinical Consultant and Technical Consultant. Review of the Annual Evaluation of Testing Personnel Competency for Testing Personnel A to G, dated 11/09/2023 showed they were signed by Testing Personnel A. Review of the Annual Evaluation of Testing Personnel Competency for Testing Personnel A, B, and C, dated 04/11/2022 showed they were signed by Testing Personnel A. On 12/08/2022 at 12:53 PM, Testing Personnel A stated it was her signature on the competency evaluations for 2022 and 2023. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 9, 2021

Survey Type: Standard

Survey Event ID: TVJ311

Deficiency Tags: D2007 D0000

Summary:

Summary Statement of Deficiencies D0000 A recertification survey was conducted September 9, 2021. Florida Pediatric Group PA clinical laboratory was not in compliance with 42 CFR 493, requirements for clinical laboratories. D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to have all testing personnel rotate through performance of proficiency testing (PT) samples for 6 of 6 events (2019 3rd, 2020 1st, 2nd 3rd, 2021 1st, 2nd) for the specialty of hematology. Findings: Review of the American Proficiency Institute PT showed Testing Personnel A was the only staff that had signed the attestation forms as the person performing PT. Review of the Laboratory Personnel Report signed and dated by the Laboratory Director on 09/07/2021 showed there were 4 testing personnel. Review of the 2019 Laboratory Personnel Report signed and dated by the Laboratory Director on 08/06 /2019 showed all four of the current testing personnel were also listed as testing personnel in 2019. On 09/09/2021 at 12:10 PM, Testing Personnel A stated she was the only person who performed the PT. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 6, 2019

Survey Type: Standard

Survey Event ID: FJ6O11

Deficiency Tags: D2122 D0000 D5469

Summary:

Summary Statement of Deficiencies D0000 A Recertification survey was conducted on August 10, 2019. Florida Pediatric Group PA was not in compliance with 42 CFR 493, requirements for clinical laboratories. D2122 HEMATOLOGY CFR(s): 493.851(b) Failure to attain an overall testing event score of at least 80 percent is unsatisfactory performance. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to receive a passing proficiency test (PT) score for the second testing event of 2018 for the specialty of Hematology. Findings: Review of the PT Performance Summary from American Proficiency Institute (API) for the second event of 2018 showed unsatisfactory scores for the CMS (Center for Medicare & Medicaid Services) reportable analytes of Erythrocyte Count (20%), Hematocrit (60%), and Hemoglobin (80%). The overall score for the specialty of hematology was 76% (Erythrocyte count 20% + Hematocrit 60% + Hemoglobin 80% + Leukocyte Count 100% + Platelet Count 100% + White Blood Cell Differential 100% = 460% divided by 6 analytes = 77%). During an interview on 8/06/19 at 1:30 PM, Testing Personnel A confirmed the laboratory had failed proficiency testing. D5469 CONTROL PROCEDURES CFR(s): 493.1256(d)(10)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- Establish or verify the criteria for acceptability of all control materials. (i) When control materials providing quantitative results are used, statistical parameters (for example, mean and standard deviation) for each batch and lot number of control Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- materials must be defined and available. (ii) The laboratory may use the stated value of a commercially assayed control material provided the stated value is for the methodology and instrumentation employed by the laboratory and is verified by the laboratory. (iii) Statistical parameters for unassayed control materials must be established over time by the laboratory through concurrent testing of control materials having previously determined statistical parameters. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to perform quality control lot to lot comparisons from 8/06/17 to 8/06/19 for hematology. Findings: Review of the quality control logs showed that there were no lot to lot comparisons of the hematology controls from 8/06/17 to 8/06/19 for the Horiba ABX Micros 60 and the Cell Dyn Emerald hematology analyzers. During an interview on 8/06/19 at 2:32 PM, Testing Personnel A acknowledged that the laboratory did not perform quality control lot to lot comparisons. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access